Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Some types of hair loss can be reversed, others are permanent, and treatments vary by type.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

Bee venom helps hair grow and may work better than some common treatments.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

The visfatin GT genotype may increase the risk of Alopecia Areata.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

Men with male pattern baldness have a higher chance of heart disease, especially if they're younger or have severe baldness; no link was found with another type of baldness called alopecia areata.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

Homeopathic treatments can effectively manage hair loss and improve well-being.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

People with alopecia areata often have lower levels of zinc and vitamin D.

Some vaccines, like the hepatitis B vaccine, might be linked to the hair loss condition Alopecia Areata, but more research is needed.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.